Mirae Asset Global Investments Co., Ltd. Taysha Gene Therapies, Inc. Call Options Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TSHA
# of Institutions
118Shares Held
137MCall Options Held
65.4KPut Options Held
41.7K-
Rtw Investments, LP New York, NY18.8MShares$30.6 Million0.7% of portfolio
-
Avoro Capital Advisors LLC New York, NY18.7MShares$30.4 Million0.57% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$19.1 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$17.7 Million0.37% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$14.7 Million2.21% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $78.8M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...